Guo Y - Search Results

1

Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.

Li C, Zhang E, Sun Y, Lee PS, Zhan Y, Guo Y, Osorio JC, Rosas IO, Xu KF, Kwiatkowski DJ, Yu JJ. Li C, et al. Among authors: guo y. PLoS One. 2014 Oct 27;9(10):e104809. doi: 10.1371/journal.pone.0104809. eCollection 2014. PLoS One. 2014. PMID: 25347447 Free PMC article.

2

Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis.

Guo Y, Kwiatkowski DJ. Guo Y, et al. Mol Cancer Res. 2013 May;11(5):467-73. doi: 10.1158/1541-7786.MCR-12-0605. Epub 2013 Feb 5. Mol Cancer Res. 2013. PMID: 23386687 Free PMC article.

3

Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells.

Li C, Lee PS, Sun Y, Gu X, Zhang E, Guo Y, Wu CL, Auricchio N, Priolo C, Li J, Csibi A, Parkhitko A, Morrison T, Planaguma A, Kazani S, Israel E, Xu KF, Henske EP, Blenis J, Levy BD, Kwiatkowski D, Yu JJ. Li C, et al. Among authors: guo y. J Exp Med. 2014 Jan 13;211(1):15-28. doi: 10.1084/jem.20131080. Epub 2014 Jan 6. J Exp Med. 2014. PMID: 24395886 Free PMC article.

4

Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.

Guo Y, Dreier JR, Cao J, Du H, Granter SR, Kwiatkowski DJ. Guo Y, et al. PLoS One. 2016 Dec 1;11(12):e0167384. doi: 10.1371/journal.pone.0167384. eCollection 2016. PLoS One. 2016. PMID: 27907099 Free PMC article.

5

Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma.

Guo Y, Chirieac LR, Bueno R, Pass H, Wu W, Malinowska IA, Kwiatkowski DJ. Guo Y, et al. Oncogene. 2014 Jun 12;33(24):3151-60. doi: 10.1038/onc.2013.280. Epub 2013 Jul 15. Oncogene. 2014. PMID: 23851502 Free PMC article.

6

Molecular dissection of AKT activation in lung cancer cell lines.

Guo Y, Du J, Kwiatkowski DJ. Guo Y, et al. Mol Cancer Res. 2013 Mar;11(3):282-93. doi: 10.1158/1541-7786.MCR-12-0558. Epub 2013 Jan 14. Mol Cancer Res. 2013. PMID: 23319332 Free PMC article.

7

TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.

Guo Y, Chekaluk Y, Zhang J, Du J, Gray NS, Wu CL, Kwiatkowski DJ. Guo Y, et al. J Pathol. 2013 May;230(1):17-27. doi: 10.1002/path.4176. Epub 2013 Mar 21. J Pathol. 2013. PMID: 23401075

8

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.

Mrozek EM, Bajaj V, Guo Y, Malinowska IA, Zhang J, Kwiatkowski DJ. Mrozek EM, et al. Among authors: guo y. PLoS One. 2021 Apr 23;16(4):e0248380. doi: 10.1371/journal.pone.0248380. eCollection 2021. PLoS One. 2021. PMID: 33891611 Free PMC article.

9

Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.

Chekaluk Y, Wu CL, Rosenberg J, Riester M, Dai Q, Lin S, Guo Y, McDougal WS, Kwiatkowski DJ. Chekaluk Y, et al. Among authors: guo y. PLoS One. 2013 Apr 4;8(4):e60927. doi: 10.1371/journal.pone.0060927. Print 2013. PLoS One. 2013. PMID: 23593348 Free PMC article.

10

Response and acquired resistance to everolimus in anaplastic thyroid cancer.

Wagle N, Grabiner BC, Van Allen EM, Amin-Mansour A, Taylor-Weiner A, Rosenberg M, Gray N, Barletta JA, Guo Y, Swanson SJ, Ruan DT, Hanna GJ, Haddad RI, Getz G, Kwiatkowski DJ, Carter SL, Sabatini DM, Jänne PA, Garraway LA, Lorch JH. Wagle N, et al. Among authors: guo y. N Engl J Med. 2014 Oct 9;371(15):1426-33. doi: 10.1056/NEJMoa1403352. N Engl J Med. 2014. PMID: 25295501 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41,320 results

Search Page